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Introduction
Dengue fever virus belongs to the Flaviviridae family and is
transmitted to humans via the Aedes Aegypti mosquito.
Dengue virus (DENV) is prevalent in tropical and subtropical
regions and infects 50-100 million people per year. Dengue
fever was first identified as a problem in Pakistan after an
outbreak in 1994.1 DENV has since become endemic to
Pakistan, causing infections throughout the year, particularly
since 2005.2 It is associated with a seasonal variation, mainly
in the post-monsoon period, i.e. July - November.2,3
Dengue infections vary from mild dengue fever (DF) to
severe dengue haemorrhagic fever (DHF) and dengue
shock syndrome (DSS) manifestations.4 Management of
dengue infections is mainly via supportive care and there is
no specific treatment for DENV. Rapid diagnosis is essential
for improved and early treatment and management of
dengue infections. Viraemia occurs during the first week of
clinical symptoms of DF. At this time, direct detection of the
virus by either viral ribonucleic acid (RNA) detection or viral
antigen detection is appropriate. After the first week, the
host antibody response to the virus develops and during
this time the viraemia is reduced and host immunoglobulin
M (IgM) levels rise after 5-7 days, followed by
immunoglobulin G (IgG) levels after a few weeks.
Primary dengue infections occur when an individual is
infected with DENV for the first time whilst secondary
dengue infectionsoccur in individualswhohavehaddengue
infection previously. Secondary DENV infections result in
more immune mediated damage and a greater chance of
progression from dengue fever to DHF or DSS. In a dengue-
endemic region, there is a higher risk of secondary infections.
Therefore, in patients with prior dengue infections, it is
particularly important to get rapid early diagnosis of the
disease. Severity of infections has also been associated with
different dengue genotypes worldwide. In Pakistan, mainly
dengue type 3 has been found prevalent but other types—
1, 2 and 4— are also reported.5,6
Appropriate diagnostics for DENV are linked to the phase of
clinical infection in the infected individual.7,8 Until recently,
diagnosis of dengue infections was based on serology or
immunochromatographic testing for host IgM or IgG. With
newdengue diagnostics, there has been improvement in the
rapidity with which early viral diagnosis can be made. This
includesdirect detectionof the virus antigen suchas thenon-
structural protein-1 (NS1) or detection of viral RNA by reverse
transcription polymerase chain reaction (RT-PCR). Dengue
virus NS1 antigen (DENAG) and test for DENV RNA by reverse
transcription PCR (DEN-PCR) positivity is coincident with the
early viraemic stageof the first 5daysof initial infection,whilst
immunochromatic assay and for human IgM against DENV
(DEN-IgM) levels usually come up after 5 days of infection.7
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Abstract
Objective: To evaluate the trends in usage of dengue virus diagnostics in Pakistan.
Methods: This retrospective study was conducted at the Aga Khan University Hospital, Karachi, and comprised data
for specimens tested for dengue virus from January 2012 to December 2015. Test for dengue virus ribonucleic acid
by reverse transcription polymerase chain reaction, dengue virus antigen by immunochromatic assay and for
human immunoglobulin M against dengue virus by enzyme-linked immunosorbent assay were reviewed. SPSS 17
was used for data analysis.
Results: Overall, 33,577 specimens tested for dengue virus. Of them, 11,995 (35.7%) were positive. among them,
1,039(8.66%) were reported in 2012; 5,791(48.28%) in 2013; 1,027(8.56%) in 2014; and 4,138(34.49%) in 2015. In
2012, 966(93%) of the positive samples were diagnosed by immunoglobulin M-based method and 73(7%) by non-
structural protein-1 antigen. In 2013, 4,401(76%) samples were tested positive by immunoglobulin M, 1,332(23%) by
antigen and 58(1%) by polymerase chain reaction. The trend continued in 2014, but in 2015, 2,111(51%) of all
dengue positive tests were determined by antigen testing, 1,969(47.6%) by immunoglobulin M and 58(1.4%) by
polymerase chain reaction.
Conclusion: There was a shift in usage of direct virus identification for rapid diagnosis of dengue virus compared
with host immunoglobulin M testing.
Keywords: Dengue virus, Diagnostics, NS1 antigen, Dengue PCR, Dengue IgM. (JPMA 67: 548; 2017)
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DENAG is most useful in diagnosis of primary dengue, as in
secondary infections, the effectiveness of antigen based
diagnosis is reduced due to the presence of previously
circulating IgG antibodies to DENV from a primary infection.
However, DEN-PCR is effective for diagnosis for both primary
and secondary dengue infections.
The current study was planned to evaluate the
consistent seasonality of DENV and also the
changing trends for dengue diagnostics in
Pakistan.
Materials and Methods
This retrospective study was conducted at the Aga
Khan University Hospital (AKUH), Karachi, and
comprised data for specimens tested for DENV
from January 1, 2012 to December 31, 2015.
Approval for the study was obtained from the
institutional ethics review committee.
Data, obtained from the laboratory records of the
AKUH, was collected for DENV IgM, DENV NS1
antigen and DENV PCR tests. Demographic data
regarding age and gender of the study subjects
from whom the specimens had been obtained
was available, but clinical information was not.
The AKUH's clinical laboratory has 226 collection
points throughout Pakistan, with 76 in Karachi
alone. For each test, whole blood samples were
collected and serum was separated from the
samples and stored at -80°C. Samples from
collection points outside Karachi were transported
on dry ice to the main lab for testing.
Serum samples were tested for DENV IgM using
the PanBio, enzyme-linked immunosorbent assay
(ELISA) kit as permanufacturer's recommendations
(PanBio Assay, Brisbane, Australia).
Serum samples were used to test for DENV NS-1
antigen using an immunochromatographic test,
according to the manufacturer's recommendations
(PanBio Assay, Brisbane, Australia). RNA was
extracted from 150 µl of serum using the
Nucleospin kit for DENV RT-PCR. A one-step RT-PCR
kit (Superscript, Invitrogen, United States) was used
to amplify extracted RNA from clinical samples. The
assay format employed 2 parallel PCR reactions
using extracted RNA from a clinical sample in a real-
time PCR reaction. The first primer pair detected
DEN 1- 3, while the second primer probe detected
DEN4. In each case, a probe with a 6-
carboxyfluorescein (6-FAM) label and a quencher
(Black Hole Quencher, BHQ®) was used to detect
DENV-positive amplicons, as described by Drosten et al.9
Statistical analysis was performed using SPSS 17.
Results
Of the 33,577samples tested, 11,995(35.7%) were positive
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Figure-1: Trends of Dengue virus testing (2012-2015). A: Monthly distribution of total cases tested
(bar graphs) and those positive for Dengue virus (line graph) in each year. B: The proportion of samples
received at AKUH from different regions of Karachi. C: The regional distribution of dengue positive
samples received from Pakistan.
AKUH: Aga Khan University Hospital. DENV: Dengue virus. KPK: Khyber Pakhtunkhwa
for DENV. Of them, 1,039(8.66%) were reported in 2012;
5,791(48.28%) in 2013; 1,027(8.56%) in 2014; and
4,138(34.49%) in 2015. Increase in positive samples was
observedbetween July andDecember each year, coincident
with the monsoon and post-monsoon season (Figure-1A).
Moreover, 9,647(80.4%) cases were from Karachi. Of them,
4,799(50%) cases were from in-patient specimens, followed
by Karachi Cantonment 946(9.8%), South District 884(9%),
Central 1,613(16.7%) and East 833(8.6%) (Figure-1B).
Furthermore, 1,823(15.2%) cases were reported from
interior Sindh followed by Punjab, Khyber Pakhtunkhwa
(KPK) and Balochistan (Figure-1C).
Of all the patients tested positive for DENV, 9,557(80%)
were males and 2,438(20%) were
females. The overall median age was
28 years, (Inter-quartile range [IQR]:
19-43). The median age of females
was 29 (IQR: 20-43) years and that of
males was 29 (IQR: 19-45) years.
Besides, more positive samples were
obtained from males compared to
females in all regions (Table).
Of all the samples, 22,444(66.8%)
were tested by DEN-IgM,
10,839(32.3%) using DENAG and
294(0.9%) by DEN-PCR.
However, the trend in the usage of
dengue diagnostics changed during
the study period. In 2012, 966(93%) of
the positive samples were diagnosed
by DEN-IgM and 73(7%) by DENAG. In
2013, 4,401(76%) samples were tested
positive by DEN-IgM, 1,332(23%) by
DENAG and 58(1%) by PCR. During
2014, the same trend in the usage and
proportion of DENAG and DEN-IgM
positive tests was found. However, in
2015, 2,111(51%) of all denguepositive
tests were determined by DENAG testing, 1,969(47.6%) by
DEN-IgM and 58(1.4%) byDEN-PCR (Figure-2).
Discussion
Our data reflects a change in the usage of dengue
diagnostics with increase in direct and rapid diagnostics
compared to indirect antibody-based testing. It illustrates
that the paradigm of dengue testing changed over a 4-
year period from 2012 to 2015. Earlier, there was mainly
indirect dengue virus testing based on human IgM. Later
on, it changed to a combination of IgM and direct DENV
antigen and PCR-based testing.
There were 1,039 dengue cases in 2012, which increased by
more than 5.5 times to the highest level in 2013. Moreover,
40% of all tested specimens were found to be positive for
the virus. In each year, dengue virus positivity rose between
themonths of July andNovember. In Pakistan, themonsoon
rains usually occur during themonths July andAugust. Post-
monsoon, there is often flooding and collection of water,
leading to favourable conditions for water-borne diseases
and breeding of mosquito larvae. The higher levels of
dengue infections observed in 2013 are consistent with the
high levels of post-monsoon flooding.
The usage of DENV diagnostics for positive tests showed a
decrease for indirect IgM-based diagnosis from 93% in
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NS1: Non-structural protein-1
DENAG: Dengue virus non-structural protein-1 antigen
RT-PCR: Reverse transcription polymerase chain reaction
DEN-PCR: Test for dengue virus by reverse transcription polymerase chain reaction
IgM: Immunoglobulin M; DEN-IgM: Host immunoglobulin M against dengue virus.
Figure-2: Diagnosis of Dengue virus according to test modality. The data illustrates the number of Dengue virus positive
cases detected by Dengue antigen (DENAG, NS1), Dengue RT-PCR (DEN-PCR) and host IgM (DEN-IGM) based testing.
Table: Gender based distribution of Dengue positive specimens.
Female (%) Male (%) T o t a l
Number
Karachi 2324 (24.1) 7323 (75.9) 9647
Interior Sindh 56 (3.1) 1767 (96.9) 1823
Punjab 41 (12.7) 282 (87.3) 323
KPK 13 (8.7) 137 (91.3) 150
Balochistan 4 (7.7) 48 (92.3) 52
All regions 2438 (20) 9557 (80) 11995
KPK: Khyber Pakhtunkhwa.
2012 to 47% in 2015. This was balanced by usage of direct
DENV antigen and PCR-based testing from 7% in 2012 to
52% in 2015.
Most samples tested were from the province of Sindh,
primarily from Karachi, probably due to the location of the
test facility. As the samples were collected nationwide, they
represent ongoing nationwide trends that have followed the
introduction of new dengue diagnostic tests at the AKUH.
Karachi has an estimated population of approximately 20
million. Of the Karachi districts, most samples were
received from the Central region, comprised now of
Liaquatabad Town, North Nazimabad Town, Gulberg Town
and New Karachi Town. This may be related to the higher
number of large health care facilities present in the region,
resulting in an increased number of samples submitted.
The difference in dengue positive tests between males
and females is probably associated with the health-
seeking behaviour of the population. Men are likely to get
more medical care than women due to social and
economic reasons.10
A limitation of our study was that we did not have clinical
information on the patients who had been tested for
dengue and, therefore, it was not possible to estimate the
impact of the change in trends of dengue virus diagnostics.
Also, as the AKUH is in Karachi, most samples receivedwere
from the same region, although representative samples
from other provinces were available.
Rapid early diagnosis of dengue infections is important in
management of the disease as it allows improved treatment
leading to better disease outcomes. Therefore, this is a
positive outcome for dengue diagnostic testing in Pakistan.
A recent paper has described that when early diagnosis by
DEN-PCR or NS1 antigen diagnosis was combined with IgM
testing, the overall rates of diagnosis for dengue were >
90%.8 Hence, in a resource-poor endemic setting where
only a one-time sample may be possible, it would be
advisable to perform both kinds of tests simultaneously.
In addition, rapid diagnosis of DENV in the early phase
becomes important to distinguish from other
haemorrhagic fever, such as Congo-Crimean
Haemorrhagic Fever Virus (CCHF), which is important in a
region endemic for both dengue and CCHF viruses.11
There are additional haemorrhagic fever viruses present
in Pakistan, such as Chikungunya and West Nile viruses,12
hence these should be considered in cases where results
for DENV were found to be negative.
Ultimately, it is necessary to remove mosquito breeding to
reduce the rates of dengue infections. Prevention of dengue
virus growth and human disease requires public health
interventionalmeasures to restrictmosquitopopulations and
increasing public awareness regarding personal protection
and reducing conditions that allow dengue larvae growth.
Conclusion
There was a shift in the usage of direct virus identification
for rapid diagnosis of dengue virus as compared with host
IgM-based testing. The usage of both direct and indirect
virus testing should facilitate improved management and
outcome of the disease.
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